Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

被引:0
|
作者
Ming Shi
机构
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Palliative treatment; Prognosis;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
AIM:To identify prognostic factors from pretreatment variables of the initial transarterial chemoembolization(TACE)procedure in unresectable hepatocellular carcinoma(HCC). METHODS:One thousand and five hundred and sixtynine patients with unresectable HCC underwent TACE as initial treatment were retrospectively studied.Pretreatment variables of the initial TACE procedure with a P value less than 0.05 by univariate analysis were subjected to Cox proportional hazards model. RESULTS:The median overall survival time and 1-, 5-,10-year survival rates were 10.37 mo,47%,10%, and 7%,respectively.A Cox proportional hazard model showed that 8 pretreatment factors of regional lymphnodes metastasis,Child-Pugh class,macrovascular invasion,greatest dimension,α-fetoprotein(AFP), Hepatitis virus B,tumor capsule,and nodules were independent prognostic factors.Patients with multimodality therapy have better survival than those with TACE treatment only. CONCLUSION:Tumor status,hepatic function reserve,AFP,and hepatitis virus B status were independent prognostic factors for unresectable HCC.Distant metastasis might not be a contraindication to TACE. Multimodality therapy might improve survival.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 50 条
  • [41] Transarterial chemoembolization of hepatocellular carcinoma
    Huppert, Peter
    RADIOLOGIE, 2022, 62 (03): : 225 - 233
  • [42] Transarterial chemoembolization for hepatocellular carcinoma
    Lau, WY
    Yu, SCH
    Lai, ECH
    Leung, TWT
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (01) : 155 - 168
  • [43] TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
    Vremera, Teodora
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (01): : 182 - 182
  • [44] Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A comparative retrospective study
    Zhang, Jin-Xing
    Chen, Yu-Xing
    Zhou, Chun-Gao
    Liu, Jin
    Liu, Sheng
    Shi, Hai-Bin
    Zu, Qing-Quan
    HEPATOLOGY RESEARCH, 2022, 52 (09) : 794 - 803
  • [45] Transarterial chemoembolization, celecoxib and lanreotide in treatment of hepatocellular carcinoma
    Tang, Chengwei
    Li, Xiao
    Tong, Huan
    Wei, Bo
    Zhang, Mingguang
    Huang, Zhiyin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 21 - 21
  • [46] Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma
    White, Jared A.
    Redden, David T.
    Bryant, Mary Kate
    Dorn, David
    Saddekni, Souheil
    Aal, Ahmed Kamel Abdel
    Zarzour, Jessica
    Bolus, David
    Smith, J. Kevin
    Gray, Stephen
    Eckhoff, Devin E.
    DuBay, Derek A.
    HPB, 2014, 16 (12) : 1095 - 1101
  • [47] Effectiveness of transarterial chemoembolization combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma
    Cao, Fei
    Yang, Yi
    Si, Tongguo
    Luo, Jun
    Zeng, Hui
    Zhang, Zhewei
    Chen, Yi
    Zheng, Jiaping
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [48] TRANSARTERIAL CHEMOEMBOLIZATION TO THE TREATMENT OF HEPATOCELLULAR CARCINOMA - PREPARATION PROCEDURES
    Ferreira, D.
    Pires, T.
    Machado, N.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E107 - E107
  • [49] Sorafenib in Combination With Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
    Geschwind, Jean-Francois H.
    Chapiro, Julius
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (08) : 585 - 587
  • [50] Adjuvant transarterial chemoembolization to sorafenib in unresectable hepatocellular carcinoma: A meta-analysis
    Chen, Anxin
    Li, Shijie
    Yao, Zhiyuan
    Hu, Jiahao
    Cao, Jiasheng
    Topatana, Win
    Juengpanich, Sarun
    Yu, Hong
    Shen, Jiliang
    Chen, Mingyu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (02) : 302 - 310